Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells. Its proprietary platform technology is an automatic procedure to encapsulate small and large molecules, including therapeutic enzymes, in patients’ red blood cells, where the cells are re-infused into patients.